Anderson’s Pediatric Cardiology

1. Introduction - p. 335 2. Bradyarrhythmias - p. 335 3. Syncope - p. 340 4. Tachyarrhythmias - p. 341 5. Supraventricular Arrhythmias - p. 341 6. Ventricular Arrhythmias - p. 350 7. Channelopathies - p. 351 8. Arrhythmias in Adults With Congenital Heart Disease - p. 356 9. Electrophysiologic Testing - p. 357 10. Pacemakers and Defibrillators - p. 364 11. Implantable Cardioverter/Defibrillators - p. 366 12. Cardiac Resynchronization Therapy - p. 367 13. Pacemaker Function and Follow-up - p. 368 14. Arrhythmias Following Congenital Heart Disease Surgery - p. 374 15. Annotated References - p. 378.e1 16. References - p. 378.e1 17. 23 Cardiopulmonary Exercise Testing - p. 379 18. 24 Pediatric Cardiovascular Data, Analysis, and Critical Appraisal of the Literature - p. 403 19. 25 Cardiovascular Risk Factors in Youth - p. 423 20. Section 4 Specific Lesions - p. 437.e7 21. 26 Isomerism of the Atrial Appendages - p. 441 22. 27 Anomalous Systemic Venous Return - p. 457 23. 28 Pulmonary Venous Abnormalities - p. 475 24. 29 Interatrial Communications - p. 503 25. 30 Division of Atrial Chambers (“Cor Triatriatum”) - p. 517 26. 31 Atrioventricular Septal Defects - p. 521 27. 32 Ventricular Septal Defect - p. 555 28. 33 Diseases of the Tricuspid Valve - p. 585 29. 34 Diseases of the Mitral Valve - p. 607 30. 35 Tetralogy of Fallot With Pulmonary Stenosis - p. 631 31. 36 Tetralogy of Fallot With Pulmonary Atresia - p. 653 32. 37 Transposition - p. 675 33. 38 Congenitally Corrected Transposition - p. 697 34. 39 Double-Outlet Ventricle - p. 715 35. 40 Common Arterial Trunk - p. 741 36. 41 Arterial Duct - p. 755 37. 42 Pulmonary Stenosis - p. 775 38. 43 Pulmonary Atresia With Intact Ventricular Septum - p. 803 39. 44 Congenital Anomalies of the Aortic Valve and Left Ventricular Outflow Tract - p. 819 40. 45 Coarctation and Interrupted Aortic Arch - p. 843 41. 46 Congenital Coronary Anomalies - p. 865 42. 47 Vascular Rings, Pulmonary Arterial Sling, and Related Conditions - p. 877 43. 48 Artery of the Fifth Aortic Arch - p. 901 44. 49 Abnormal Positions and Relationships of the Heart - p. 913 45. 50 Arteriovenous Communications - p. 927 46. 51 Other Malformations of the Ventricular Outflow Tracts - p. 945 47. 52 Cardiac Tumors - p. 963 48. 53 Kawasaki Disease - p. 979 49. 54 Acute Rheumatic Fever - p. 997 50. 55 Chronic Rheumatic Heart Disease - p. 1023 51. 56 Infective Endocarditis - p. 1043 52. 57 Pericardial Diseases in Children - p. 1063 53. 58 Aortopathies in Pediatric Cardiology and Cardiac Surgery - p. 1077 54. 59 Cardiologic Aspects of Systemic Disease - p. 1087 55. Abstract - p. 1087 56. Metabolic Disorders: Storage Diseases - p. 1087 57. Endocrine Disorders - p. 1095 58. Disorders of Energy Metabolism - p. 1097 59. Disorders of Collagen Synthesis or Extracellular Matrix - p. 1098 60. Neuromuscular Diseases - p. 1102 61. Nutritional Deficiencies - p. 1107 62. Deposition Diseases - p. 1108 63. Autoimmune Diseases - p. 1109 64. Heart Disease Induced by Toxins - p. 1111 65. Miscellaneous Systemic Disorders - p. 1112 66. Summary - p. 1113 67. Annotated References - p. 1113.e1 68. References - p. 1113.e1 69. 60 Systemic Hypertension - p. 1115 70. Abstract - p. 1115 71. Introduction - p. 1115 72. Evaluation of Blood Pressure: Measurement, Normal Values, and Important Influences - p. 1115 73. Hypertension - p. 1124 74. Medical Therapy - p. 1139 75. References - p. 1142.e1 76. Section 5 Heart Failure and Transplantation - p. 1142.e8 77. 61 Cardiomyopathies - p. 1145 78. 62 Cardio-oncology - p. 1167 79. 63 Myocarditis - p. 1173 80. 64 Acute Circulatory Failure - p. 1179 81. 65 Chronic Heart Failure - p. 1193 82. 66 Chronic Mechanical Circulatory Support - p. 1205 83. 67 Heart and Heart-Lung Transplantation - p. 1217 84. Section 6 Functionally Univentricular Heart - p. 1239.e3 85. 68 Introduction - p. 1243 86. 69 Anatomic Considerations in the Functionally Univentricular Heart - p. 1245 87. 70 Physiologic Principles to Maximize Outcome in Patients With a Functionally Univentricular Heart - p. 1261 88. 71 Fontan Pathway From Birth Through Early Childhood - p. 1273 89. Abstract - p. 1273 90. Introduction - p. 1273 91. Neonatal Stabilization, Surgical Strategies, and Postoperative Management - p. 1273 92. Second-Stage Palliation: The Superior Cavopulmonary Connection - p. 1296 93. Third-Stage Reconstruction: The Modified Fontan Procedure - p. 1300 94. Outcomes Along the Fontan Pathway - p. 1304 95. Future Considerations - p. 1305 96. Closing Thoughts - p. 1306 97. Annotated References - p. 1306.e1 98. References - p. 1306.e1 99. 72 Interstage Management - p. 1307 100. 73 Longer-Term Outcomes and Management for Patients With a Functionally Univentricular Heart - p. 1317 101. Abstract - p. 1317 102. Evolution of the Fontan Procedure - p. 1317 103. Late Outcome With a Fontan Circulation - p. 1317 104. Late Predictors - p. 1320 105. Consequences of the Fontan Circulation - p. 1320 106. Impaired Exercise Capacity (see also Chapter 23) - p. 1321 107. Arrhythmia (see also Chapter 22) - p. 1324 108. Summary - p. 1329 109. Hematologic and Immunologic Complications - p. 1329 110. Fontan-Associated Liver Disease - p. 1331 111. Neurocognitive and Psychosocial Function - p. 1334 112. Management of the “Well” Fontan - p. 1336 113. Cardiac Catheterization and Transcatheter Intervention - p. 1340 114. Management of Fontan Failure - p. 1342 115. Future Directions - p. 1348 116. Annotated References - p. 1351.e1 117. References - p. 1351.e1 118. Section 7 Beyond the Heart - p. 1351.e10 119. 74 Systemic Circulation - p. 1355 120. Abstract - p. 1355 121. Introduction - p. 1355 122. Systemic Arterial System - p. 1355 123. Modeling of the Systemic Circulation - p. 1359 124. Measurement of Arterial Function - p. 1362 125. Systemic Arterial Dysfunction in Childhood - p. 1370 126. Ventriculoarterial Interaction - p. 1375 127. The Future - p. 1379 128. Annonated References - p. 1379.e1 129. References - p. 1379.e1 130. 75 Pulmonary Hypertension - p. 1381 131. 76 Neurodevelopmental and Psychosocial Outcomes in Children and Young Adults With Complex Congenital Cardiac Disease - p. 1393 132. 77 Congenital Cardiac Disease in the Setting of Genetic Syndromes - p. 1407 133. 78 Acute and Chronic Renal Consequences of Cardiac Disease in Children - p. 1421 134. 79 Pharmacogenetics in the Treatment of Congenital and Acquired Cardiac Disease During Childhood - p. 1429 135. 80 Pregnancy and Congenital Heart Disease - p. 1441 136. 81 Preparing the Young Adult With Complex Congenital Cardiac Disease to Transfer From Pediatric to Adult Care - p. 1451 137. 82 Psychological and Social Aspects of Pediatric Cardiac Disease - p. 1455 138. 83 Ethical Issues in Pediatric Cardiology and Congenital Heart Disease - p. 1465 139. 84 Clinical Care Pathways Supporting the Care of Children and Young People With Congenital Heart Disease - p. 1481 140. 85 Discharge Planning, Communications With the Team Providing Care in the Ambulatory Setting and the “Medical Home” - p. 1487 141. 86 Growth and Nutrition - p. 1495 142. 87 Quality Improvement in Congenital Cardiac Disease - p. 1505 143. 88 Global Burden of Pediatric Heart Disease and Pediatric Cardiac Care in Low- and Middle-Income Countries - p. 1519 144. 89 Screening in Pediatric and Congenital Cardiac Disease - p. 1535 145. 90 Anesthetic Considerations for Cardiac and Noncardiac Surgery in the Child With Congenital Cardiac Disease - p. 1547 146. 91 Telemedicine in Pediatric Cardiology - p. 1553 147. Index - p. 1561